research Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
In this study, four children with recurrent atypical teratoid rhabdoid tumors experienced disease stabilization or regression after treatment with alisertib, suggesting its potential role in future trials for this condition.